Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis

• Xiao-min Ren ,

  Contributed equally to this work with: Xiao-min Ren, Guang-feng Zuo

  Affiliation Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Qinhuai, Nanjing 210006, P.R. China

  ⨯
• Guang-feng Zuo ,

  Contributed equally to this work with: Xiao-min Ren, Guang-feng Zuo

  Affiliation Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Qinhuai, Nanjing 210006, P.R. China

  ⨯
• Wen Wu,

  Affiliation Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Qinhuai, Nanjing 210006, P.R. China

  ⨯
• Jie Luo,

  Affiliation Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Qinhuai, Nanjing 210006, P.R. China

  ⨯
• Peng Ye,

  Affiliation Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Qinhuai, Nanjing 210006, P.R. China

  ⨯
• Shao-liang Chen ,

  * E-mail: chen_s_l0931@sina.com (SLC); huzy0073@163.com (ZYH)

  Affiliation Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Qinhuai, Nanjing 210006, P.R. China

  ⨯
• Zuo-ying Hu

  * E-mail: chen_s_l0931@sina.com (SLC); huzy0073@163.com (ZYH)

  Affiliation Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Qinhuai, Nanjing 210006, P.R. China

  ⨯